Results 201 to 210 of about 2,377,916 (241)
Some of the next articles are maybe not open access.
Advances in Antiarrhythmic Drug Therapy
1992Publisher Summary Recently, electrophysiologic studies have suggested that the arrhythmias leading to sudden cardiac death may have a different mechanism and pathophysiology from those producing frequent premature ventricular contractions. This has led to the speculation that agents that affect the duration of the action potential and His-Purkinje ...
D C, Harrison, M B, Bottorff
openaire +2 more sources
Future Trends in Antiarrhythmic Therapy
Journal of Cardiovascular Pharmacology, 1991It is difficult to define what the trends will be in antiarrhythmic therapy in the coming years, particularly at a time when rhythmology has been somewhat destabilized by the unexpected results of large therapeutic trials on sudden death prevention. Schematically, drugs that do have established antiarrhythmic properties do not provide any benefit, and ...
openaire +2 more sources
Antiarrhythmic Therapy for Ventricular Arrhythmias
Journal of Cardiovascular Pharmacology, 1991Treatment of ventricular arrhythmias has received great attention during the past 20 years. However, results of recent trials with class I antiarrhythmic drugs in patients after myocardial infarction have raised many questions about the risk-benefit ratio of antiarrhythmic therapy, at least in asymptomatic subjects.
openaire +2 more sources
The American Journal of Nursing, 1980
J L, Stanford, J M, Felner, D, Arensberg
openaire +2 more sources
J L, Stanford, J M, Felner, D, Arensberg
openaire +2 more sources
Amiodarone in the antiarrhythmic therapy
Pharmacological Research Communications, 1983F, Furlanello +5 more
openaire +2 more sources
Cardiology, 2008
A number of conventional and newer antiarrhythmic agents are available for the treatment and prophylaxis of ventricular tachycardia and sudden death. Using a multifaceted approach of programmed electrical stimulation studies, drug level determinations, exercise tolerance testing, and 24-hour ambulatory electrocardiographic monitoring, the physician can
openaire +1 more source
A number of conventional and newer antiarrhythmic agents are available for the treatment and prophylaxis of ventricular tachycardia and sudden death. Using a multifaceted approach of programmed electrical stimulation studies, drug level determinations, exercise tolerance testing, and 24-hour ambulatory electrocardiographic monitoring, the physician can
openaire +1 more source
Advances in Antiarrhythmic Therapy
JAMA, 1982THE APPROACH to the management of disorders of cardiac rhythm has undergone major changes in the last ten years. 1,2 The early experience with surgery and with pacemakers suggests that these modes of therapy hold much promise; however, it is unlikely that they will have a major appeal for the largest numbers of patients needing antiarrhythmic therapy ...
openaire +1 more source
Comparative Evaluation of Antiarrhythmic Therapy
Drugs, 1985Kappenberger L, SCHWARTZ, PETER
openaire +2 more sources
[Guidelines for antiarrhythmic therapy].
Nihon rinsho. Japanese journal of clinical medicine, 2002Recentry, therapies for arrhythmias have been extremely advanced by accumulation of electrophysiological knowledge, improvement of diagnostic technique, and development of antiarrhythmic drugs and devices(pacemakers, catheter ablation and implantable cardioverter-defibrillators).
Yoko, Hagiwara, Satoshi, Ogawa
openaire +1 more source